Reply to “Correspondence: SPARC, HEG1, and the Diagnosis of Epithelioid Mesothelioma” by Churg et al

*Department of Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University Hiroshima, Japan

†Department of Surgical Oncology Research Institute for Radiation Biology and Medicine, Hiroshima University Hiroshima, Japan

Conflicts of Interest and Source of Funding: The authors disclose that they have no relationship with or financial interest in any commercial company involved in this article.

留言 (0)

沒有登入
gif